Elliott Advisors, an activist investor with a 1% stake in GSK, recommends GSK to add board members with medical expertise. A. Given that Modigliani and Miller show that leverage is irrelevant to firm value, one could argue that financial expertise is not important. Therefore, one could replace board members with financial expertise with those that have expertise in their products. Would you agree with this statement, and why? B. Give two examples how changes in capital structure can increase firm value and describe them in detail.